Private placement in SpinChip Diagnostics AS (NO) – NOK 65 million

Carnegie acted as manager and sole bookrunner in SpinChip Diagonostics’ private placement of NOK 65 million in new equity. Representing the future of point-of-care testing, SpinChip Diagnostics was founded in Norway in 2012. SpinChip’s proprietary platform is focused on in vitro diagnostics (IVD) to develop diagnostic tests for acute and chronic cardiac indications where test results are rapidly needed to provide patients with life-saving treatments.
April 2023.